*A randomised, double-blind, multicentre, three-arm, Phase II study. Treatment success of body psoriasis according to PGA at Week 4, defined as clear or almost clear from baseline for patients with moderate/severe disease and clear from baseline for those with mild disease.1
**A Phase II, multicentre, investigator-blinded study. Treatment success was defined as patients who achieved clear or almost clear skin with at least a two-step improvement according to the PGA.2
CI, confidence interval; OR, odds ratio; PGA, physician’s global assessment.
Lebwohl M et al. J Clin Aesthet Dermatol 2016;9(2):34–41.
Koo J et al. J Dermatolog Treat 2016; 27(2):120–127.
UK/IE MAT-04319 V4
Date of preparation: September 2018
Cookies on this site